0.37
-0.0079(-2.12%)
Currency In USD
Address
888 Seventh Avenue
Boston, NY 10106
United States of America
Phone
716 371 1125
Sector
Healthcare
Industry
Biotechnology
Employees
34
First IPO Date
June 25, 2021
| Name | Title | Pay | Year Born |
| Mr. Joseph J. Ferra Jr. | Chief Executive Officer, President & Director | 931,579 | 1975 |
| Ms. Tammy Furlong CPA, P.M.P. | Chief Financial Officer & Secretary | 0 | 1972 |
| Mr. Robert C. Yang | Senior Vice President & General Counsel | 0 | N/A |
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.